Hepatitis C: Recent Advances
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Interferon-alpha in hepatitis C. Dosage, costs and benefits.
Briggs A, Shiell A Pharmacoeconomics. 1996; 10(3):205-9.
PMID: 10163569 DOI: 10.2165/00019053-199610030-00002.
References
1.
Di Bisceglie A, Shindo M, Fong T, Fried M, Swain M, Bergasa N
. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology. 1992; 16(3):649-54.
DOI: 10.1002/hep.1840160307.
View
2.
Lau J, Davis G, Kniffen J, Qian K, Urdea M, Chan C
. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 1993; 341(8859):1501-4.
DOI: 10.1016/0140-6736(93)90635-t.
View
3.
Nishiguchi S, Kuroki T, Ueda T, Fukuda K, Takeda T, Nakajima S
. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med. 1992; 116(1):21-5.
DOI: 10.7326/0003-4819-116-1-21.
View
4.
Seeff L, Wright E, Durako S, Alter H, Iber F, Hollinger F
. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med. 1992; 327(27):1906-11.
DOI: 10.1056/NEJM199212313272703.
View
5.
Weiner A, Kuo G, Bradley D, Bonino F, Saracco G, Lee C
. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet. 1990; 335(8680):1-3.
DOI: 10.1016/0140-6736(90)90134-q.
View